Development of Acute Pancreatitis Due to Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis B: A Case Report
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.21, no.1, pp.35-37, 2015 (ESCI, TRDizin)
- Publication Type: Article / Article
- Volume: 21 Issue: 1
- Publication Date: 2015
- Doi Number: 10.4274/vhd.69875
- Journal Name: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
- Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Page Numbers: pp.35-37
- Keywords: Chronic hepatitis B, pegylated interferon alpha 2a, acute pancreatitis
- Open Archive Collection: AVESIS Open Access Collection
- Dokuz Eylül University Affiliated: No
Abstract
Interferons (IFNs) are immunomodulatory and antiviral agents used in the treatment of chronic hepatitis B and C. Development of acute pancreatitis is a very rare complication seen during IFN (pegylated or standard) treatment in chronic viral hepatitis. In this report, we present a 50-year-old patient with chronic renal insufficiency and chronic hepatitis B who developed acute pancreatitis during treatment with peg-IFN alpha-2a.